Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
3Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

President and CEO of Boston Scientific Corporation since November 2012 and Chairman since May 2016. Previously Worldwide Chairman of Medical Devices and Diagnostics division at Johnson & Johnson. Spent 12 years at General Electric Medical Systems in various leadership roles including General Manager of Healthcare Information Technology business.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Lead Independent Director

CVS Health (NYSE: CVS)

Apr 4, 2025 – Present

Independence: Not stated

Source effective: 2026-04-03 · Observed: 2026-05-15T19:57:55.368747+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Lead Independent Director

CVS Health

2025-04-04 · current

Confirmed by public sourceView source

Chair

Boston Scientific

2012-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Boston Scientific

Open Boston Scientific profile →

Chair at Boston Scientific

2012-01-01 → End not stated

current · source reported

Observed: 2026-09-24

Boston ScientificBoston ScientificCVS HealthCVS HealthMichael F. Mahoney

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingPublic profile sourceSupports Lead Independent Director at CVS Health (NYSE: CVS).Open sourceSource 2 · Sec FilingBSX DEF 14A executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:michael-f-mahoney
Record version
public-0

Published evidence records

9 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Open source

    sec filing · Source published: Apr 3, 2026 · Retrieved: May 15, 2026

    Supports 1 claim
    • Professional Role: Lead Independent Director at CVS Health · Claim reviewed: May 15, 2026

  2. BSX DEF 14A executive officers

    sec filing · Source published: Mar 18, 2026 · Retrieved: May 4, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Boston Scientific Corporation · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chairman of the Board, President and Chief Executive Officer · Claim reviewed: May 4, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  3. BSX DEF 14A director slate

    sec filing · Source published: Mar 18, 2026 · Retrieved: May 15, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Chair · Claim reviewed: May 15, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Boston Scientific Corporation · Claim reviewed: May 15, 2026
    • Executive title: Executive title: President and Chief Executive Officer · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  4. Boston Scientific Corporation director board source

    sec filing · Source published: Mar 18, 2026 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Not independent (executive director) · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Boston Scientific Corporation · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of CVS Health · Claim reviewed: May 3, 2026

  5. Open source

    sec proxy · Source published: Mar 18, 2026 · Retrieved: Mar 21, 2026

    Supports 1 claim
    • Professional Role: Chair at Boston Scientific · Claim reviewed: May 15, 2026

  6. CVS DEF 14A director slate

    sec filing · Source published: Apr 4, 2025 · Retrieved: May 15, 2026

    Supports 2 claims
    • Board role: Board role: Lead Independent Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Management Planning and Development, Nominating and Corporate Governance, Executive · Claim reviewed: May 15, 2026

  7. BSX executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance reported from role and filings · Claim reviewed: May 3, 2026
    • Executive company: Executive at Boston Scientific Corporation · Claim reviewed: May 15, 2026
    • Executive function: Enterprise Leadership (CEO) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Chairman of the Board, President and Chief Executive Officer · Claim reviewed: May 4, 2026

  8. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of CVS Health · Claim reviewed: May 3, 2026

  9. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Boston Scientific Corporation · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

AI expertise · Source reportedAI expertise: not identified in the cited filing1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

AI governance relevance · Source reportedAI governance relevance reported from role and filings1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board independence · Source reportedNot independent (executive director)1 source
Verification
Source reported
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of Boston Scientific CorporationSupported by 3 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of CVS HealthSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · Source reportedBoard role: Chair1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board role · Source reportedBoard role: Lead Independent Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedNo committee assignment disclosed in the cited filing1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Management Planning and Development, Nominating and Corporate Governance, Executive1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · CorroboratedExecutive at Boston Scientific CorporationSupported by 3 public records3 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive function · Source reportedEnterprise Leadership (CEO)1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · CorroboratedExecutive title: Chairman of the Board, President and Chief Executive OfficerSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Executive title · Source reportedExecutive title: President and Chief Executive Officer1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources9 records
  1. https://www.sec.gov/Archives/edgar/data/0000064803/000130817925000386/cvs012729_def14a.htm

    Sec Filing · Tier not stated · Reviewed May 15, 2026

    Supports: Lead Independent Director at CVS Health (NYSE: CVS)

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  4. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Director since · Board independence

  5. https://www.sec.gov/Archives/edgar/data/885725/000088572526000025/bsx-20260318.htm

    Sec Proxy · Tier not stated · Reviewed Mar 21, 2026

    Supports: Chair at Boston Scientific (NYSE: BSX)

  6. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  7. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: AI expertise · AI governance relevance · Executive company · Executive function · Executive title

  8. https://www.sec.gov/Archives/edgar/data/0000064803/000130817925000386/cvs012729_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  9. https://www.sec.gov/Archives/edgar/data/885725/000088572526000025/bsx-20260318.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership